15 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp08327 | Sample Peptide 1 from EP3604345B1 | MQIPQAPWPVVWAVLQLGWRKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 / WST-8 | NCI-H2444 | Lung Cancer | Cell Viability = 6.8% at 25 μM |
| dbacp08328 | Sample Peptide 1 from EP3604345B1 | MQIPQAPWPVVWAVLQLGWRKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 / WST-8 | HCC-827 | Lung Cancer | Cell Viability = 11.8% at 25 μM |
| dbacp08329 | Sample Peptide 1 from EP3604345B1 | MQIPQAPWPVVWAVLQLGWRKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 / WST-8 | NCI-H446 | Lung Cancer | Cell Viability = 0.5% at 25 μM |
| dbacp08330 | Sample Peptide 1 from EP3604345B1 | MQIPQAPWPVVWAVLQLGWRKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 / WST-8 | A-2058 | Skin Cancer | Cell Viability = 6.7% at 25 μM |
| dbacp08331 | Sample Peptide 1 from EP3604345B1 | MQIPQAPWPVVWAVLQLGWRKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 / WST-8 | MDA-MB-231 | Breast Cancer | Cell Viability = 62.3% at 25 μM |
| dbacp08332 | Sample Peptide 2 from EP3604345B1 | MQIPQAPWPVVWAVLQLGWRRKKRRQRRR | Synthetic | Not Available | CCK-8 / WST-8 | NCI-H2444 | Lung Cancer | Cell Viability = 3.6% at 25 μM |
| dbacp08333 | Sample Peptide 2 from EP3604345B1 | MQIPQAPWPVVWAVLQLGWRRKKRRQRRR | Synthetic | Not Available | CCK-8 / WST-8 | HCC-827 | Lung Cancer | Cell Viability = 4.9% at 25 μM |
| dbacp08334 | Sample Peptide 2 from EP3604345B1 | MQIPQAPWPVVWAVLQLGWRRKKRRQRRR | Synthetic | Not Available | CCK-8 / WST-8 | A-549 | Lung Cancer | Cell Viability = 9.1% at 25 μM |
| dbacp08335 | Sample Peptide 3 from EP3604345B1 | MRIFAVFIFMTYWHLLNAKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 / WST-8 | NCI-H2444 | Lung Cancer | Cell Viability = 87.7% at 25 μM |
| dbacp08336 | Sample Peptide 3 from EP3604345B1 | MRIFAVFIFMTYWHLLNAKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 / WST-8 | HCC-827 | Lung Cancer | Cell Viability = 120.6% at 25 μM |
| dbacp08337 | Sample Peptide 3 from EP3604345B1 | MRIFAVFIFMTYWHLLNAKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 / WST-8 | NCI-H446 | Lung Cancer | Cell Viability = 56.7% at 25 μM |
| dbacp08338 | Sample Peptide 3 from EP3604345B1 | MRIFAVFIFMTYWHLLNAKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 / WST-8 | A-2058 | Skin Cancer | Cell Viability = 87.5% at 25 μM |
| dbacp08339 | Sample Peptide 3 from EP3604345B1 | MRIFAVFIFMTYWHLLNAKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 / WST-8 | MDA-MB-231 | Breast Cancer | Cell Viability = 81.7% at 25 μM |
| dbacp08340 | Sample Peptide 4 from EP3604345B1 | PWWWPPVVVQQQMILLIGAARKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 / WST-8 | HCC-827 | Lung Cancer | Cell Viability = 102.6% at 25 μM |
| dbacp08341 | Sample Peptide 5 from EP3604345B1 | KKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 / WST-8 | HCC-827 | Lung Cancer | Cell Viability = 106.5% at 25 μM |